Carbapenem and colistin resistance in Enterobacteriaceae in Southeast Asia: Review and mapping of emerging and overlapping challenges
- PMID: 31369812
- DOI: 10.1016/j.ijantimicag.2019.07.019
Carbapenem and colistin resistance in Enterobacteriaceae in Southeast Asia: Review and mapping of emerging and overlapping challenges
Abstract
Carbapenem-resistant Enterobacteriaceae infections have spread globally, leaving polymyxins, including colistin, as 'last-resort treatments'. Emerging colistin resistance raises the spectre of untreatable infections. Despite this threat, data remain limited for much of the world, including Southeast Asia where only 3 of 11 nations submitted data on carbapenem and colistin resistance for recent World Health Organization (WHO) reports. To improve our understanding of the challenge, we utilised broad strategies to search for and analyse data on carbapenem and colistin resistance among Escherichia coli and Klebsiella in Southeast Asia. We found 258 studies containing 526 unique reports and document carbapenem-resistant E. coli and Klebsiella in 8 and 9 of 11 nations, respectively. We estimated carbapenem resistance proportions through meta-analysis of extracted data for nations with ≥100 representative isolates. Estimated resistance among Klebsiella was high (>5%) in four nations (Indonesia, Philippines, Thailand and Vietnam), moderate (1-5%) in two nations (Malaysia and Singapore) and low (<1%) in two nations (Cambodia and Brunei). For E. coli, resistance was generally lower but was high in two of seven nations with ≥100 isolates (Indonesia and Myanmar). The most common carbapenemases were NDM metallo-β-lactamases and OXA β-lactamases. Despite sparse data, polymyxin resistance was documented in 8 of 11 nations, with mcr-1 being the predominant genotype. Widespread presence of carbapenem and polymyxin resistance, including their overlap in eight nations, represents a continuing risk and increases the threat of infections resistant to both classes. These findings, and remaining data gaps, highlight the urgent need for sufficiently-resourced robust antimicrobial resistance surveillance.
Keywords: Antimicrobial resistance; Asia; Carbapenems; Colistin; Enterobacteriaceae; Epidemiology.
Published by Elsevier B.V.
Similar articles
-
Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa.Antimicrob Resist Infect Control. 2023 Apr 4;12(1):29. doi: 10.1186/s13756-023-01220-4. Antimicrob Resist Infect Control. 2023. PMID: 37013626 Free PMC article.
-
Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene mcr-1 in CRE in a Hospital in Henan, China.J Clin Microbiol. 2018 Mar 26;56(4):e01932-17. doi: 10.1128/JCM.01932-17. Print 2018 Apr. J Clin Microbiol. 2018. PMID: 29386265 Free PMC article.
-
Review and mapping of carbapenem-resistant Enterobacteriaceae in Africa: Using diverse data to inform surveillance gaps.Int J Antimicrob Agents. 2018 Sep;52(3):372-384. doi: 10.1016/j.ijantimicag.2018.05.019. Epub 2018 Jun 2. Int J Antimicrob Agents. 2018. PMID: 29864500 Review.
-
Emergence and nosocomial spread of carbapenem-resistant OXA-232-producing Klebsiella pneumoniae in Brunei Darussalam.J Glob Antimicrob Resist. 2017 Jun;9:96-99. doi: 10.1016/j.jgar.2017.02.008. Epub 2017 Apr 27. J Glob Antimicrob Resist. 2017. PMID: 28458051
-
Risk factors for, and molecular epidemiology and clinical outcomes of, carbapenem- and polymyxin-resistant Gram-negative bacterial infections in pregnant women, infants, and toddlers: a systematic review and meta-analyses.Ann N Y Acad Sci. 2021 Oct;1502(1):54-71. doi: 10.1111/nyas.14650. Epub 2021 Jul 2. Ann N Y Acad Sci. 2021. PMID: 34212401
Cited by
-
Whole genome-based genetic insights of blaNDM producing clinical E. coli isolates in hospital settings of Pakistan.Microbiol Spectr. 2023 Sep 5;11(5):e0058423. doi: 10.1128/spectrum.00584-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37668386 Free PMC article.
-
Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions.Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2053-2068. doi: 10.1007/s10096-021-04296-1. Epub 2021 Jun 24. Eur J Clin Microbiol Infect Dis. 2021. PMID: 34169446 Free PMC article. Review.
-
Global trends and current status in colistin resistance research: a bibliometric analysis (1973-2019).F1000Res. 2020 Jul 31;9:856. doi: 10.12688/f1000research.25124.1. eCollection 2020. F1000Res. 2020. PMID: 33456760 Free PMC article.
-
Prevalence of colistin-resistant Enterobacteriaceae isolated from clinical samples in Africa: a systematic review and meta-analysis.BMC Infect Dis. 2025 Mar 29;25(1):437. doi: 10.1186/s12879-025-10826-5. BMC Infect Dis. 2025. PMID: 40158103 Free PMC article.
-
Environmental contamination with carbapenem resistant Acinetobacter baumannii in healthcare settings in Fiji: a potential source of infection.Front Cell Infect Microbiol. 2024 Sep 23;14:1429443. doi: 10.3389/fcimb.2024.1429443. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39376664 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical